Raymond Alexander Alfred Smith

Raymond Alexander Alfred Smith

Auto-generated profile, based on publicly available information

Raymond Alexander Alfred Smith

School of Chemical Engineering, The University of Queensland , Brisbane, QLD 4072

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2014 in Journal of the American Chemical Society
Verified
Journal Article
Open access
MHMia L. Huang
Mia L. Huang
RSRaymond A. A. Smith
Raymond A. A. Smith
GTGreg W. Trieger
Greg W. Trieger
KGKamil Godula
Kamil Godula
Growth factor (GF) signaling is a key determinant of stem cell fate. Interactions of GFs with their receptors are often mediated by heparan sulfate proteoglycans (HSPGs). Here, we report a cell surface engineering strategy that exploits the function of HSPGs to promote differentiation in embryonic stem cells (ESCs). We have generated synthetic neoproteoglycans (neoPGs) with affinity for the fibroblast growth factor 2 (FGF2) and introduced them into plasma membranes of ESCs deficient in HS biosynthesis. There, the neoPGs assumed the function of native HSPGs, rescued FGF2-mediated kinase activity, and promoted neural specification. This glycocalyx remodeling strategy is versatile and may be applicable to other types of differentiation.

19 January 2011 in Biochemical Society Transactions
Verified
Journal Article
Closed access
RSRaymond A.A. Smith
Raymond A.A. Smith
KMKate Meade
Kate Meade
CPClaire E. Pickford
Claire E. Pickford
RHRebecca J. Holley
Rebecca J. Holley
CMCathy Merry
Cathy Merry
ES (embryonic stem) cell differentiation is dependent on the presence of HS (heparan sulfate). We have demonstrated that, during differentiation, the evolution of specific cell lineages is associated with particular patterns of GAG (glycosaminoglycan) expression. For example, different HS epitopes are synthesized during neural or mesodermal lineage formation. Cell lines mutant for various components of the HS biosynthetic pathway are selectively impaired in their differentiation, with lineage-specific effects observed for some lines. We have also observed that the addition of soluble GAG saccharides to cells, with or without cell-surface HS, can influence the pace and outcome of differentiation, again highlighting specific pattern requirements for particular lineages. We are combining this work with ongoing studies into the design of artificial cell environments where we have optimized three-dimensional scaffolds, generated by electrospinning or by the formation of hydrogels, for the culture of ES cells. By permeating these scaffolds with defined GAG oligosaccharides, we intend to control the mechanical environment of the cells (via the scaffold architecture) as well as their biological signalling environment (using the oligosaccharides). We predict that this will allow us to control ES cell pluripotency and differentiation in a three-dimensional setting, allowing the generation of differentiated cell types for use in drug discovery/testing or in therapeutics.

1 November 2018 in Biomaterials
Verified
Journal Article
Closed access
RSRaymond A.A. Smith
Raymond A.A. Smith
SMSadasivam Murali
Sadasivam Murali
BRBina Rai
Bina Rai
XLXiaohua Lu
Xiaohua Lu
ZLZophia Xue Hui Lim
Zophia Xue Hui Lim
SCSimon M. Cool
Simon M. Cool

24 August 2015 in Glycobiology
Verified
Journal Article
Closed access
PDF file
JLJonathan Lee
Jonathan Lee
SWSheena Wee
Sheena Wee
JGJayantha Gunaratne
Jayantha Gunaratne
RCR J E Chua
R J E Chua
RSRaymond A A Smith
Raymond A A Smith
SCSimon M. Cool
Simon M. Cool
Transforming growth factor-β1 (TGF-β1, Uniprot: P01137) is a heparin-binding protein that has been implicated in a number of physiological processes, including the initiation of chondrogenesis by human mesenchymal stem cells (hMSCs). Here we identify the molecular features in the protein and in heparin required for binding and their effects on the potentiation of TGF-β1's activity on hMSCs. Using a proteomics “Protect and Label” approach, lysines K291, K304, K309, K315, K338, K373, K375 and K388 were identified as being directly involved in binding heparin. Competition assays in an optical biosensor demonstrated that TGF-β1 does require N- and 6-O-sulphate groups for binding, but that 2-O-sulphate groups are unlikely to underpin the interaction. Heparin-derived oligosaccharides as short as degree of polymerisation (dp) 4 have a weak ability to compete for TGF-β1 binding to heparin, which increases with the length of the oligosaccharide to reach a maximum between dp18 and dp24. In cell-based assays heparin, 2-O-, 6-O- and N-desulphated re-N-acetylated heparin, and oligosaccharides 14-24 saccharides (dp14-24) in length all increased the phosphorylation of SMAD2 after 6 h stimulation with TGF-β1. The results provide the structural basis for a model of heparin/HS binding to TGF-β1 and demonstrate that features in the polysaccharide required for binding are not identical to those required for sustaining the signalling by TGF-β1 in hMSCs.

25 February 2022 in Cytotherapy
Verified
Journal Article
Closed access
ASAkshaya Srinivasan
Akshaya Srinivasan
PSPadmapriya Sathiyanathan
Padmapriya Sathiyanathan
LYLu Yin
Lu Yin
TLTong Ming Liu
Tong Ming Liu
ALAlan Lam
Alan Lam
SCSimon M. Cool
Simon M. Cool

27 November 2018 in ACS Chemical Biology
Verified
Journal Article
Closed access
Olga ZubkovaOlga Zubkova
Olga Zubkova
YAYassir A. Ahmed
Yassir A. Ahmed
SGScott E. Guimond
Scott E. Guimond
SNSophia-Louise Noble
Sophia-Louise Noble
JMJohn Miller
John Miller
JTJeremy E. Turnbull
Jeremy E. Turnbull